1 Min Read
May 8 (Reuters) - Axsome Therapeutics Inc
* Axsome therapeutics receives fda fast track designation for axs-05 for alzheimer’s disease agitation Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.